Ovarian endocrine function through five years of continuous treatment with NORPLANT® subdermal contraceptive implants
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 41 (2) , 169-177
- https://doi.org/10.1016/0010-7824(90)90145-l
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Estradiol plasma levels during long-term treatment with norplantR subdekmal implantsContraception, 1988
- Pregnancy after removal of NORPLANTR implants contraceptiveContraception, 1987
- Recovery of fertility and outcome of planned pregnancies after the removal of NORPLANTR subdermal implants or Copper-T IUDsContraception, 1987
- Ovulation detection following removal of levonorgestrel subdermal contraceptive implantsContraception, 1987
- Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term NORPLANT® useContraception, 1986
- Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of NORPLANTR implantsContraception, 1985
- Hormonal changes during the first year of use of subdermal levonoregestrel implants, NORPLANT®Contraception, 1984
- Plasma progesterone levels during long-term treatment with levonorgestrel silastic implantsActa Endocrinologica, 1982
- Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraceptionContraception, 1978
- Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrelContraception, 1976